Related Experiment Video
Updated: Aug 7, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple
L A Haglund1, G R Istre, D A Pickett
1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Abstract:
Relatively penicillin-resistant pneumococci have caused 10% of invasive pneumococcal disease in central Oklahoma during the last decade, but almost no high-level penicillin or other antibiotic resistance has been described. This study evaluated antibiotic susceptibility and serotype distribution in invasive pneumococcal disease in the Oklahoma City metropolitan area (1990 population 848,000). A total of 144 cases of invasive infection was collected in 1 year (17 with meningitis, 120 with other bacteremic infections, and 7 with other invasive infections), for a rate of 16.9/100,000 (95% confidence interval [CI], 14.0-19.5). For the population aged > or = 60, invasive pneumococcal disease rates were higher among nursing home residents (352/100,000) than among nonresidents (25.6/100,000; relative risk, 13.7; 95% CI, 7.7-24.7). Antibiotic-resistant organisms caused 19.4% of the cases: relative penicillin resistance, 7.6%; high-level penicillin resistance, 1.4% (2 cases), and 11% resistance to erythromycin, trimethoprim-sulfamethoxazole, or both, with 5% sharing both resistances plus a MIC of penicillin of 0.06 microgram/mL.
Insights
Antibiotic resistance in invasive pneumococcal disease is a growing concern. This study in Oklahoma found significant rates of penicillin and other antibiotic resistance in pneumococcal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Invasive pneumococcal disease (IPD) remains a significant public health concern.
- Understanding antibiotic resistance patterns is crucial for effective treatment and prevention strategies.
- Previous data from central Oklahoma indicated low levels of high-level antibiotic resistance in pneumococci.
Purpose of the Study:
- To evaluate the antibiotic susceptibility and serotype distribution of invasive pneumococcal disease (IPD) in the Oklahoma City metropolitan area.
- To determine the prevalence of antibiotic resistance in *Streptococcus pneumoniae* isolates causing IPD.
- To assess IPD rates in different demographic groups, including the elderly and nursing home residents.
Main Methods:
- A prospective study collected 144 cases of IPD over one year in the Oklahoma City metropolitan area.
- Antibiotic susceptibility testing was performed on *Streptococcus pneumoniae* isolates.
- Demographic data, including age and residency (nursing home vs. non-resident), were collected to calculate disease rates.
Main Results:
- The overall incidence of IPD was 16.9 cases per 100,000 population.
- Antibiotic-resistant organisms accounted for 19.4% of IPD cases.
- Relative penicillin resistance was observed in 7.6% of isolates, with high-level penicillin resistance in 1.4%. Resistance to erythromycin and/or trimethoprim-sulfamethoxazole was 11%, with 5% exhibiting dual resistance.
- IPD rates were substantially higher in nursing home residents (352/100,000) compared to non-residents (25.6/100,000) in the elderly population (≥60 years).
Conclusions:
- Antibiotic resistance, particularly relative penicillin resistance, is present in invasive pneumococcal disease in Oklahoma City.
- The findings highlight the need for ongoing surveillance of antibiotic resistance patterns in *Streptococcus pneumoniae*.
- Targeted prevention and treatment strategies may be necessary for high-risk populations like elderly nursing home residents.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Antibiotic Resistance
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction

